Multi-leu peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents
AssigneeLa Societe de Commercialisation des Produits de la Recherche Appliquee Socpra-Sciences Sante et Humaines S.E.C.
InventorsRobert Day, Martin Fugére, Witold A. Neugebauer
Life of this patent
Estimating the term…
Abstract
Disclosed herein are PACE4 inhibitors, compositions comprising PACE4 inhibitors and their uses thereof for lowering PACE4 activity, reducing cell proliferation, reducing tumor growth, reducing metastasis formation, preventing and/or treating cancer. Also provided are methods for lowering PACE4 activity, reducing the proliferation of a cell, reducing tumor growth and/or treating and preventing cancer. Methods for screening PACE4 inhibitors and cell proliferation inhibitors are further provided.
Claims11
A method of reducing the proliferation of a cell with increased Paired basic Amino acid Cleaving Enzyme (PACE) 4 activity in a subject, comprising administering a PACE 4 inhibitor comprising a peptide sequence comprising the following formula:
- Y-Arg4-Val3-Lys2-Arg1-NH2;
- wherein
- Y comprises the formula Z-Xaa8-Xaa7-Xaa6-Xaa5, wherein
- Xaa5, Xaa6, Xaa7 and Xaa8 are Leu, Iso or Val;
- Z is absent or comprises an N-terminal acyl group linked to the N-terminal of the peptide sequence;
- thereby reducing the proliferation of the cell in the subject.
Dependencies are inferred from the claim text.